Cardia International A/SAktiv

CVR 35812563

Økonomiske nøgletal

-654.742 kr.+66,6%
Bruttofortjeneste 2025/26
-2 mio.-1,5 mio.-1 mio.-500 t.02024/252025/26

Nøgletal

2025/26
Balancens sammensætning
OmsætningsaktiverAnlægsaktiverGæld og hensatte forpligtelserEgenkapital
05 mio.10 mio.2024/252025/26
Regnskabstal2025–2026
2024/252025/26
Balance — aktiver
Likvide beholdninger55.704367.465
Omsætningsaktiver i alt3.254.7533.087.000
Anlægsaktiver i alt74.60074.600
Aktiver i alt3.329.3533.161.600
Balance — passiver
Kortfristede gældsforpligtelser8.453.5829.074.284
Langfristede gældsforpligtelser——
Gældsforpligtelser i alt8.453.5829.074.284
Selskabskapital746.000746.000
Overført resultat-5.870.229-6.658.684
Årets resultat-2.381.620-788.455
Egenkapital i alt-5.124.229-5.912.684
Resultatopgørelse
Bruttofortjeneste-1.958.213-654.742
Resultat af primær drift-2.324.297-654.742
EBITDA-1.958.213-654.742
Resultat før skat-2.381.620-788.455
Årets resultat-2.381.620-788.455
Personaleomkostninger——
Af- og nedskrivninger366.0850
Andre nøgletal
Ansatte00

En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.

Om virksomheden

Årsrapport 2026

Description of key activities of the companyCardia International A/S is manufacturing and selling the defibrillator CardiAid.

Significant changes in the company's activities and financial mattersThere have been no significant changes in activities and financial matters. The gross loss for the year totals EUR -88.000 thousand against EUR -262.000 thousand last year. Loss from ordinary activities after tax totals EUR -106.000 thousand against EUR -319.000 thousand last year. Management considers the net loss for the year as expected. The Company has incurred losses and has negative equity as of 31 March 2026. Furthermore, contrary to prior years, the parent company has not issued a support letter for the coming financial year. Management has prepared cash flow forecasts for the period ending 31 March 2027 and has assessed the Company’s expected liquidity requirements and available financing options. Based on the current forecast, anticipated operating performance and the ongoing dialogue with the Company’s stakeholders, management expects that the Company will be able to meet its obligations as they fall due. However, the absence of a support letter from the parent company represents a material uncertainty which may cast significant doubt on the Company’s ability to continue as a going concern. The annual report has nevertheless been prepared on a going concern basis, as management considers the assumptions applied in the liquidity forecast to be reasonable.

Uddrag af ledelsesberetningen i den seneste årsrapport.

Cardia International A/S — cvrprofil.dk